Upgrades
- HCP (HCP) upgraded by UBS from Neutral to Buy
- CyberArk (CYBR) upgraded by Summit Research from Sell to Hold
- Royal Bank of Canada (RY) upgraded by Citigroup from Neutral to Buy
- Toronto-Dominion (TD) upgraded by Citigroup from Neutral to Buy
- Priceline (PCLN) upgraded by Stifel from Hold to Buy
- R.R. Donnelley (RRD) upgraded by Benchmark Co. from Hold to Buy
- ImmunoGen (IMGN) upgraded by Cantor from Hold to Buy
- Mechel (MTL) upgraded by Deutsche Bank from Sell to Hold
- Coronado (CNDO) upgraded by MLV & Co. from Hold to Buy
- Liberty Media (LMCA) upgraded by Buckingham from Neutral to Buy
[ad#upgrades-336]
Downgrades
- Auspex Pharmaceuticals (ASPX) downgraded by Stifel from Buy to Hold
- Auspex Pharmaceuticals (ASPX) downgraded by RW Baird from Outperform to Neutral
- Cypress Energy (CELP) downgraded by Wunderlich from Buy to Hold
- Hyperion Therapeutics (HPTX,HZNP) downgraded by Cantor from Buy to Hold
- Hyperion Therapeutics (HPTX) downgraded by Needham from Buy to Hold
- OFG Bancorp (OFG) downgraded by Guggenheim from Buy to Neutral
- Echo Global (ECHO) downgraded by BB&T from Buy to Hold
- Catamaran (CTRX) downgraded by SunTrust from Buy to Neutral
[ad#ia-bret]
Upgrades & Downgrades provided by Theflyonthewall.com 
TheFlyOnTheWall.com is a source for up-to-the-minute financial news. Known for its unbiased market intelligence, TheFly has been serving professional and individual investors worldwide for more than 12 years. TheFly’s news feed keeps investors informed of all the news moving on the wires and circulating throughout Wall Street trading desks. Become an informed investor. Try all of TheFly’s services FREE for 30-days by clicking here.